Innovative Roswell Park Radiation Therapy Protocol in Lung Cancer to Be Highlighted at ASTRO Annual Meeting - Scorecard - MDSpire

Innovative Roswell Park Radiation Therapy Protocol in Lung Cancer to Be Highlighted at ASTRO Annual Meeting

Experts from Roswell Park Comprehensive Cancer Center will share the findings of a novel approach using radiation therapy to treat lung cancer at the American Society for Radiation Oncology (ASTRO) Annual Meeting Sept. 27-Oct. 1, 2025, in San Francisco.

  • By

  • September 23, 2025

  • 3 min

Share

Clinical Scorecard: Innovative Roswell Park Radiation Therapy Protocol in Lung Cancer to Be Highlighted at ASTRO Annual Meeting

At a Glance

CategoryDetail
ConditionNon-Small Cell Lung Cancer (NSCLC)
Key MechanismsSingle-fraction stereotactic body radiation therapy post-surgery
Target PopulationPatients with non-small cell lung cancer post-surgery
Care SettingOncology department at Roswell Park Comprehensive Cancer Center

Key Highlights

  • Presentation of a novel radiation therapy approach at ASTRO Annual Meeting
  • Single-arm, prospective clinical trial evaluating post-operative radiation therapy
  • Study led by Dr. Anurag Singh, focusing on feasibility and toxicity analysis

Guideline-Based Recommendations

Diagnosis

  • Evaluate patients with non-small cell lung cancer for surgical intervention

Management

  • Consider single-fraction stereotactic body radiation therapy post-surgery

Monitoring & Follow-up

  • Assess for potential toxicity and treatment outcomes in post-operative patients

Risks

  • Monitor for adverse effects associated with high-dose radiation therapy

Patient & Prescribing Data

Post-operative non-small cell lung cancer patients

Single high dose of radiation may improve treatment outcomes

Clinical Best Practices

  • Implement early initiation of radiation therapy when appropriate
  • Utilize a multidisciplinary approach in managing lung cancer patients

References

Original Source(s)

Innovative Roswell Park Radiation Therapy Protocol in Lung Cancer to Be Highlighted at ASTRO Annual Meeting

  • by

  • September 23, 2025

Related Content

Ultra-high-sensitivity next-generation sequencing–based MRD predicts outcome in intensively treated older patients with acute myeloid leukemia: results from the ALFA-1200 cohort

Stimuli-responsive nanoplatforms for sonodynamic immunotherapy: opportunities and challenges in cancer treatment

VANGL1 links angiogenesis–stemness programs and tumor microenvironment remodeling: a pan-cancer, multi-omics study with translational validation